Welfare-Improving Menstrual Technology Adoption in High Severity Settings

Last registered on May 06, 2024


Trial Information

General Information

Welfare-Improving Menstrual Technology Adoption in High Severity Settings
Initial registration date
April 26, 2024

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
May 06, 2024, 4:07 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.


There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Ludwig-Maximilians-Universität München

Other Primary Investigator(s)

PI Affiliation
Ludwig-Maximilians-Universität München
PI Affiliation
University of Groningen

Additional Trial Information

In development
Start date
End date
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
This study examines the adoption of menstrual health technologies in high-severity settings, focusing on the influence of social barriers on this adoption. Conducted through a randomized control trial, the research assesses two intervention groups: one receiving standard menstrual health education and products, and the other additionally involving male household members in specialized educational sessions. Initially, we explore the demand for various menstrual technology features, along with the knowledge and needs surrounding menstruation among women in communities served by Oxfam in Mali, the Central African Republic, and Somaliland. This approach allows us to understand both the direct impact of menstrual health technologies and the role of social dynamics in their adoption.
External Link(s)

Registration Citation

Castro, Silvia, Kristina Czura and Carolin Formella. 2024. "Welfare-Improving Menstrual Technology Adoption in High Severity Settings." AEA RCT Registry. May 06. https://doi.org/10.1257/rct.13507-1.0
Sponsors & Partners



Experimental Details


This study provides 750 women across Mali, the Central African Republic, and Somaliland with free reusable menstrual underwear and educational sessions on menstrual health. Each participant receives a menstrual health kit and attends four 60-minute sessions led by female moderators to enhance knowledge and discuss menstrual product use and social norms.

Additionally, the intervention includes a component for male engagement, where half of the women's household male members are invited to attend separate 60-minute educational sessions. These sessions, conducted by male moderators, emphasize supporting women’s menstrual health needs and the advantages of proper menstrual hygiene practices.
Intervention Start Date
Intervention End Date

Primary Outcomes

Primary Outcomes (end points)
Changes in knowledge about menstruation and menstrual hygiene, changes to demand for different product features, and shifts in intra-househousehold dynamics, particularly concerning male involvement and support in menstrual health practices.
Primary Outcomes (explanation)
Detailed in PAP

Secondary Outcomes

Secondary Outcomes (end points)
Social norms, and female well-being
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Control Group: Women receive menstrual health kits and attend four educational sessions focused on menstrual health, hygiene practices, and challenging social norms, facilitated by female moderators.

Treatment Group: In addition to the same kits and educational sessions as the control group, the male household members of these women are invited to attend two separate educational sessions. These sessions, led by male moderators, are designed to educate men on the importance of supporting women's menstrual health needs.
Experimental Design Details
Not available
Randomization Method
Computer randomization
Randomization Unit
Was the treatment clustered?

Experiment Characteristics

Sample size: planned number of clusters
750 individuals
Sample size: planned number of observations
750 individual
Sample size (or number of clusters) by treatment arms
375 approximately
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)

Institutional Review Boards (IRBs)

IRB Name
e Ethics Commission, Department of Economics, University of Munich
IRB Approval Date
IRB Approval Number
Project 2024-06
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information